Navigation Links
Lixte Biotechnology Holdings, Inc. Awarded Grant Under Qualifying Therapeutic Discovery Project from the U. S. Government
Date:3/2/2011

EAST SETAUKET, N.Y., March 2, 2011 /PRNewswire/ -- Lixte Biotechnology Holdings (OTC: LIXT) announced today that the company has received a $244,479.25 grant under the Qualifying Therapeutic Discovery Project (QTDP).  This grant was awarded to further development and commercialization of Lixte's novel anti-cancer compound LB-100.  The QTDP program was included as part of the Patient Protection and Affordable Care Act of 2010 to encourage development of new therapies to prevent, diagnose, and treat acute and chronic diseases.  The selection process took into consideration the potential of projects to reduce long-term healthcare costs in the United States or significantly advance the goal of curing cancer over the next 30 years.  The selections were made jointly by the Department of Health and Human Services and the Treasury Department.  

"We are extremely pleased to have qualified for this grant," said Dr. John Kovach, founder and president of Lixte. "The funds will be used as part of our effort to complete pre-clinical studies and submit an IND to the FDA to bring our novel compound LB-100 to Phase I clinical trial. LB-100 represents a new type of anti-cancer drug, which we hope will improve treatments for several different types of human cancers for which more effective therapies are urgently needed."

About Lixte Biotechnology Holdings, Inc:Lixte Biotechnology Holdings, Inc. is a cancer therapeutics company. Founded as a biomarker-diagnostics company in 2005, Lixte primary focus is discovery of new chemotherapy drugs based on targeting molecular abnormalities of common human cancers critical to their survival.

Forward-Looking StatementsThis announcement contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. For example, statements regardin
'/>"/>

SOURCE Lixte Biotechnology Holdings
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lixte Biotechnology Holdings, Inc. Announces the Approval of a Collaboration with the National Cancer Institute for Clinical Evaluation of its Lead Anti-Cancer Compound, LB-100.
2. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
3. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
4. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
5. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
6. Pharma ChemOutsourcing Targets BioNJ, PA Bio, MassBio, BayBio, SoCalBio, and NY Biotechnology Association Member Companies for September 2011 Show in New Jersey
7. Reportlinker Adds Global Biotechnology Instrumentation Industry
8. NASDAQ Removes TLCR From Biotechnology Index Pending FTC Decision on Grifols Acquisition
9. Reportlinker Adds Global Agricultural Biotechnology Industry
10. Champions Biotechnology Awarded $1.46 million in Grants
11. Goodwin Biotechnology Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... July 1, 2015 Dynatronics Corporation (the ... marketer of rehabilitation and physical therapy products, announced ... placement financing led by affiliates of Prettybrook Partners ... focused on the healthcare industry. The financing provides ... and pursue potential strategic acquisitions.  ...
(Date:7/1/2015)... -- Qiming Venture Partners, today announces the promotion of ... William has been with Qiming for nearly ... Qiming healthcare deals, and assisted many of these companies ... success in healthcare is not a small part from ... outstanding advocacy and service mentality on behalf of all ...
(Date:7/1/2015)... Lupin , Strides ... MPP Sub-licensees to Fourteen Companies     ... expansion of its network of generic manufacturers to 14 companies ... antiretrovirals (ARVs). New companies Lupin and Strides Arcolab recently signed ... the MPP licensed from ViiV Healthcare two months after its ...
Breaking Medicine Technology:Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 3Qiming Announces the Promotion of William Hu to Managing Partner 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 3
... announced today the company has reached another major milestone ... management team roster. DiFUSION Technologies is ... commercialization of its proprietary CleanFUZE ™ anti-microbial technology ... line of Posterior Interbody products. "In ...
... supplier of comprehensive patient management solutions, today introduced its ... TrendSetter collects patient compliance data from any brand of ... to home health providers. This allows the providers to ... Other solutions only work for single brands of PAP ...
Cached Medicine Technology:DiFUSION Technologies Adds Accomplished Senior Management Team 2DiFUSION Technologies Adds Accomplished Senior Management Team 3DiFUSION Technologies Adds Accomplished Senior Management Team 4DiFUSION Technologies Adds Accomplished Senior Management Team 5
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ... Dr. Divakar R. Krishnareddy, M.D., to the orthopedic and spine surgery team at ... herniations, sprains, strains, bursitis, and tendonitis. Along with the spine and spine surgery, ...
(Date:7/2/2015)... , ... July 02, 2015 ... ... janitorial supply company , announced today that it has reached an ... acquisition will make CleanItSupply.com the largest distributor of Rubbermaid Commercial Products on ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... with care and precision. There is an art and science that goes into ... of successfully reshaping the facial features and lives of more than 2,500 satisfied ...
(Date:7/2/2015)... ... , ... Real Time Pain Relief (RTPR), makers of the popular rub-on pain relief ... to sponsor The Fifth Annual Big Sky Professional Bull Riders Event being held this ... their popular pain relief lotion and products at the family friendly event that features two ...
(Date:7/2/2015)... ... July 02, 2015 , ... Breakthrough technologies are ... treatment. Dr. Lev Kalika, founder of New York Dynamic Neuromuscular Rehabilitation & ... the conservative treatment of back, hip, knee and shoulder pain as well as ...
Breaking Medicine News(10 mins):Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 2Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 3Health News:CleanItSupply.com Acquires eRubbermaid.com 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 3Health News:Real Time Pain Relief Sponsors The Fifth Annual Big Sky Professional Bull Riders Event at Big Sky Town Center in July 2Health News:Real Time Pain Relief Sponsors The Fifth Annual Big Sky Professional Bull Riders Event at Big Sky Town Center in July 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4
... In-Q-Tel Investment in Sonitus Medical Accelerates Development of ... the TeethSAN MATEO, Calif., May 26 Sonitus ... world,s first non-surgical and removable hearing device to ... strategic investment and technology advancement agreement with In-Q-Tel, ...
... on the cholesterol-lowering drugs , , MONDAY, May 25 (HealthDay News) ... risk of a second stroke, new research shows. , The ... a 35 percent lower incidence of second strokes and a ... compared to those who didn,t, according to a report in ...
... the L.A. MarathonLOS ANGELES, May 25 Today,s Los Angeles ... infamous and hugely-plumped characters from the Foster Farms television commercials. ... pass themselves off as fresh, natural and never "plumped" Foster ... entered the duo as part of its "Say No To ...
... Vienna, Austria: The relationship between the dental disease ... for several years. Although a genetic link ... Now, for the first time, scientists have discovered a ... the annual conference of the European Society of Human ...
... of trials finds Avastin with chemo doubles odds ... of the drug bevacizumab (Avastin) in combination with chemotherapy ... patients, new research has found. , These perforations are ... small intestine or large bowel. , Bevacizumab is designed ...
... woman,s death in New York City raises national toll to ... been made towards developing a viable H1N1 swine flu vaccine, ... Prevention saying this week that they have two promising candidate ... 50-year-old woman died of swine flu in New York City ...
Cached Medicine News:Health News:Sonitus Medical Secures Strategic Investment and Technology Advancement Agreement From In-Q-Tel 2Health News:Sonitus Medical Secures Strategic Investment and Technology Advancement Agreement From In-Q-Tel 3Health News:Statins Can Help Prevent Second Stroke 2Health News:Statins Can Help Prevent Second Stroke 3Health News:Scientists find shared genetic link between the dental disease periodontitis and heart attack 2Health News:Cancer Drug May Boost Risk of Gastrointestinal Perforation 2Health News:Viable Swine Flu Shot Closer to Reality 2Health News:Viable Swine Flu Shot Closer to Reality 3Health News:Viable Swine Flu Shot Closer to Reality 4Health News:Viable Swine Flu Shot Closer to Reality 5Health News:Viable Swine Flu Shot Closer to Reality 6Health News:Viable Swine Flu Shot Closer to Reality 7Health News:Viable Swine Flu Shot Closer to Reality 8Health News:Viable Swine Flu Shot Closer to Reality 9Health News:Viable Swine Flu Shot Closer to Reality 10Health News:Viable Swine Flu Shot Closer to Reality 11Health News:Viable Swine Flu Shot Closer to Reality 12Health News:Viable Swine Flu Shot Closer to Reality 13
Chemically Resistant Sealing Mat for 96ch, 1.1ml or 2.0ml, Deep Well, Round Available Sterile...
Sealing Mat for 96-well PCR Plate, Natural...
MicroAmp Full Plate Covers, which are manufactured from PCR-compatible rubber, are non-sterile, autoclavable and guaranteed reusable up to five times....
Omniseal TD mat. Reusable rubber mat for sealing PCR plates. 5 pk....
Medicine Products: